U.S. MicroRNA Market (2024 - 2030) Size, Share & Trends Analysis Report By Products & Services, By Application (Cancer, Infectious Diseases), By End-use (Biotechnology & Pharmaceutical Companies), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product& Service
                        1.2.2. Application
                        1.2.3. End-use
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in the U.S.
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Volume price analysis (Model 2)
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product& Service
                        2.2.2. Application
                        2.2.3. End-use
                    2.3. Competitive Insights
Chapter 3. MicroRNA Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. U.S. MicroRNA Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s Five Forces
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic Landscape
Chapter 4. U.S. MicroRNA Market Product & Service Estimates & Trend Analysis
                    4.1. U.S. MicroRNA Market Product & Service Dashboard
                    4.2. U.S. MicroRNA Market Product & Service Movement Analysis
                    4.3. Product
                        4.3.1. Product Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.3.2. Instruments
                            4.3.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.3.2.2. Technology
                                4.3.2.2.1. Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.2.2.2. Real-Time PCR
                                    4.3.2.2.2.1. Real-Time PCR Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.2.2.3. Microarray
                                    4.3.2.2.3.1. Microarray Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.2.2.4. NGSs
                                    4.3.2.2.4.1. NGS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.2.2.5. Others
                                    4.3.2.2.5.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.3.2.3. Workflow
                                4.3.2.3.1. Workflow Market Estimates and Forecasts, 2018 - 2030 (USD Million
                                4.3.2.3.2. Isolation & Purification
                                    4.3.2.3.2.1. Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.2.3.3. miRNA cDNA Synthesis
                                    4.3.2.3.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.2.3.4. Profiling, Localization, & Qualification
                                    4.3.2.3.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.2.3.5. Functional Analysis & Others
                                    4.3.2.3.5.1. Functional Analysis & Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.2.3.6. Others
                                    4.3.2.3.6.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.3.3. Consumables
                            4.3.3.1. Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.3.3.2. Specimen.
                                4.3.3.2.1. Specimen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.3.2.2. Whole Blood
                                    4.3.3.2.2.1. Whole Blood Market Estimates and Forecasts, 2018 - 2030 (USD Million
                                4.3.3.2.3. Serum
                                    4.3.3.2.3.1. Serum Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.3.2.4. Plasma
                                    4.3.3.2.4.1. Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.3.2.5. FFPE
                                    4.3.3.2.5.1. FFPE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.3.2.6. Fresh Frozen Tissue
                                    4.3.3.2.6.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2018 - 2030 (USD Million).
                                4.3.3.2.7. Others
                                    4.3.3.2.7.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.3.3.3. Workflow
                                4.3.3.3.1. Workflow Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.3.3.2. Isolation & Purification
                                    4.3.3.3.2.1. Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Millon)
                                4.3.3.3.3. miRNA cDNA Synthesis
                                    4.3.3.3.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.3.3.4. Profiling, Localization, & Qualification
                                    4.3.3.3.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                                4.3.3.3.5. Functional Analysis & Others
                                    4.3.3.3.5.1. Functional Analysis & Others Market Estimates and Forecasts, 2018 - 2030 (USD Mill
                                4.3.3.3.6. Others
                                    4.3.3.3.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.4. Services
                        4.4.1. Service Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.4.2. Type
                            4.4.2.1. Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.2.2. Isolation & Purification
                                4.4.2.2.1. Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.2.3. miRNA cDNA Synthesi
                                4.4.2.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.2.4. Profiling, Localization, & Qualification
                                4.4.2.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.2.5. Functional Analysis
                                4.4.2.5.1. Functional Analysis. Functional Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.2.6. Others
                                4.4.2.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.4.3. Specimen
                            4.4.3.1. Specimen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.3.2. Whole Blood
                                4.4.3.2.1. Whole Blood Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.3.3. Serum
                                4.4.3.3.1. Serum Market Estimates and Forecasts, 2018 - 2030 (USD Million).
                            4.4.3.4. Plasma
                                4.4.3.4.1. Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.3.5. FFPE
                                4.4.3.5.1. FFPE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.3.6. Fresh Frozen Tissue
                                4.4.3.6.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.3.7. Others
                                4.4.3.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. MicroRNA Market: Application Estimates & Trend Analysis
                    5.1. U.S. MicroRNA Market Application Dashboard
                    5.2. U.S. MicroRNA Market Application Movement Analysis
                    5.3. U.S. MicroRNA Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    5.4. Cancer
                        5.4.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Infectious Diseases
                        5.5.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.6. Immunological Disorder
                        5.6.1. Immunological Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.7. Cardiovascular Disease
                        5.7.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.8. Neurological Disease
                        5.8.1. Neurological Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.9. Others
                        5.9.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. MicroRNA Market: End-use Estimates & Trend Analysis
                    6.1. U.S. MicroRNA Market End-use Dashboard
                    6.2. U.S. MicroRNA Market End-use Movement Analysis
                    6.3. U.S. MicroRNA Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    6.4. Biotechnology & Pharmaceutical Companie
                        6.4.1. Biotechnology & Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. Academic & Government Research Institutes
                        6.5.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.6. Other End-use
                        6.6.1. Other End-use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company market share analysis, 2023
                            7.3.3.1. Company overview
                            7.3.3.2. Financial performance
                            7.3.3.3. Product benchmarking
                            7.3.3.4. Strategic initiatives
                        7.3.4. Thermo Fisher Scientific, Inc;
                            7.3.4.1. Company Overview
                            7.3.4.2. Financial performance
                            7.3.4.3. Product benchmarking
                            7.3.4.4. Strategic initiatives
                        7.3.5. NanoString Technologies, Inc.
                            7.3.5.1. Company overview
                            7.3.5.2. Financial performance
                            7.3.5.3. Product benchmarking
                            7.3.5.4. Strategic initiatives
                        7.3.6. BioGenex
                            7.3.6.1. Company overview
                            7.3.6.2. Financial performance
                            7.3.6.3. Product benchmarking
                            7.3.6.4. Strategic initiatives
                        7.3.7. GeneCopoeia, Inc.
                            7.3.7.1. Company overview
                            7.3.7.2. Financial performance
                            7.3.7.3. Product benchmarking
                            7.3.7.4. Strategic initiatives
                        7.3.8. New England Biolabs
                            7.3.8.1. Company overview
                            7.3.8.2. Financial performance
                            7.3.8.3. Product Benchmarking
                            7.3.8.4. Strategic initiatives
                        7.3.9. Precision Nanosystems
                            7.3.9.1. CompanOverviewew
                            7.3.9.2. Financial performance
                            7.3.9.3. Product Benchmarking
                            7.3.9.4. Strategic initiatives
                        7.3.10. Cytiva
                            7.3.10.1. CompanOverviewew
                            7.3.10.2. Financial performance
                            7.3.10.3. Product Benchmarking
                            7.3.10.4. Strategic initiatives
                        7.3.11. PerkinElmer, Inc.
                            7.3.11.1. CompanOverviewew
                            7.3.11.2. Financial performance
                            7.3.11.3. Product Benchmarking
                            7.3.11.4. Strategic initiatives
                        7.3.12. Illumina, Inc.
                            7.3.12.1. CompanOverviewew
                            7.3.12.2. Financial performance
                            7.3.12.3. Product Benchmarking
                            7.3.12.4. Strategic initiatives
                        7.3.13. AptamiR Therapeutics
                            7.3.13.1. CompanOverviewew
                            7.3.13.2. Financial performance
                            7.3.13.3. Product Benchmarking
                            7.3.13.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. MicroRNA Market, By Product & Service 2018 - 2030 (USD Billion)
Table 3 U.S. MicroRNA Market, By Application, 2018 - 2030 (USD Billion)
Table 4 U.S. MicroRNA Market, By End-use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 MicroRNA Market Segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market Trends & outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s Five Forces analysis
Fig. 14 U.S. MicroRNA Market: Product& Service outlook and key takeaways
Fig. 15 U.S. MicroRNA Market: Product& Service movement analysis & market share 2023 & 2030
Fig. 16 Global MicroRNA Market: Products & Services Movement Analysis
Fig. 17 Products Market, 2018 - 2030 (USD Million)
Fig. 18 Instruments Market, 2018 - 2030 (USD Million)
Fig. 19 Technology Market, 2018 - 2030 (USD Million)
Fig. 20 Real-Time PCR Market, 2018 - 2030 (USD Million)
Fig. 21 Microarray Market, 2018 - 2030 (USD Million)
Fig. 22 NGS Market, 2018 - 2030 (USD Million)
Fig. 23 Others Market, 2018 - 2030 (USD Million)
Fig. 24 Workflow Market, 2018 - 2030 (USD Million)
Fig. 25 Isolation & Purification Market, 2018 - 2030 (USD Million)
Fig. 26 miRNA cDNA Synthesis Market, 2018 - 2030 (USD Million)
Fig. 27 Profiling, Localization, & Quantification Market, 2018 - 2030 (USD Million)
Fig. 28 Functional Analysis & Others Market, 2018 - 2030 (USD Million)
Fig. 29 Others Market, 2018 - 2030 (USD Million)
Fig. 30 Consumables Market, 2018 - 2030 (USD Million)
Fig. 31 Specimen Market, 2018 - 2030 (USD Million)
Fig. 32 Whole Blood Market, 2018 - 2030 (USD Million)
Fig. 33 Serum Market, 2018 - 2030 (USD Million)
Fig. 34 Plasma Market, 2018 - 2030 (USD Million)
Fig. 35 FFPE Market, 2018 - 2030 (USD Million)
Fig. 36 Fresh Frozen Tissue Market, 2018 - 2030 (USD Million)
Fig. 37 Others Market, 2018 - 2030 (USD Million)
Fig. 38 Workflow Market, 2018 - 2030 (USD Million)
Fig. 39 Isolation & Purification Market, 2018 - 2030 (USD Million)
Fig. 40 miRNA cDNA Synthesis Market, 2018 - 2030 (USD Million)
Fig. 41 Profiling, Localization, & Quantification Market, 2018 - 2030 (USD Million)
Fig. 42 Functional Analysis Market, 2018 - 2030 (USD Million)
Fig. 43 Others Market, 2018 - 2030 (USD Million)
Fig. 44 Services Market, 2018 - 2030 (USD Million)
Fig. 45 Type Market, 2018 - 2030 (USD Million)
Fig. 46 Isolation & Purification Market, 2018 - 2030 (USD Million)
Fig. 47 miRNA cDNA Synthesis Market, 2018 - 2030 (USD Million)
Fig. 48 Profiling, Localization, & Quantification Market, 2018 - 2030 (USD Million)
Fig. 49 Functional Analysis Market, 2018 - 2030 (USD Million)
Fig. 50 Others Market, 2018 - 2030 (USD Million)
Fig. 51 Specimen Market, 2018 - 2030 (USD Million)
Fig. 52 Whole Blood Market, 2018 - 2030 (USD Million)
Fig. 53 Serum Market, 2018 - 2030 (USD Million)
Fig. 54 Plasma Market, 2018 - 2030 (USD Million)
Fig. 55 FFPE Market, 2018 - 2030 (USD Million)
Fig. 56 Fresh Frozen Tissue Market, 2018 - 2030 (USD Million)
Fig. 57 Others Market, 2018 - 2030 (USD Million)
Fig. 58 U.S. MicroRNA Market: Application outlook and key takeaways
Fig. 59 U.S. MicroRNA Market: Application movement analysis & market share 2023 & 2030
Fig. 60 Cancer Market, 2018 - 2030 (USD Million)
Fig. 61 Infectious Diseases Market, 2018 - 2030 (USD Million)
Fig. 62 Immunological Disorder Market, 2018 - 2030 (USD Million)
Fig. 63 Market, for cardiovascular disease Market, 2018 - 2030 (USD Million)
Fig. 64 Neurological Disease Market, 2018 - 2030 (USD Million)
Fig. 65 Others Market, 2018 - 2030 (USD Million)
Fig. 66 U.S. MicroRNAMarket: End-use and key takeaways
Fig. 67 U.S. MicroRNAMarket: End-use movement analysis & market share 2023 & 2030
Fig. 68 Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
Fig. 69 Academic & Government Research Institutes Market, 2018 - 2030 (USD Million)
Fig. 70 Other end-use Market, 2018 - 2030 (USD Million)